. Author manuscript; available in PMC: 2016 Oct 1.

Published in final edited form as: Gynecol Oncol. 2015 Aug 7;139(1):23–29. doi: 10.1016/j.ygyno.2015.08.001

Table 1.

Analysis of assosiation between the 51 patients’ age and tumor stage with overall survival (OS)

		Duke		p-value
		Short Survival (OS ≤ 3 years)	Long Survival (OS ≥ 7 years)	p-value
Stage	III	23	23	0.004
Stage	IV	5	0	0.004
Age		59 (37–79)	62 (33–78)	0.68

The stage of the tumor (III vs. IV) was significantly associated with patients OS (p-value= 0.004). However, there were only 5 patients in the stage IV group and none of the patients were in the long survival category. Age of the patients at the time of diagnosis was not significantly associated with OS (p-values= 0.68).